Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJS, Fullmer
KR, and Bush RA. CNTF
for Human Retinal Neurodegeneration: Phase I Trial of Ciliary
Neurotrophic Factor Delivered by Encapsulated Cell Intraocular
Implants for Retinitis Pigmentosa. Proc Natl Acad Sci USA,
March 7, 2006, vol. 103 no. 10
Zeiss
CJ, Allore HG, Towle V, and Tao W. CNTF
induces dose-dependent alterations in retinal morphology in normal
and rcd1 canine retina. Exp Eye Res. 2006 Mar;82(3):395-404.
Thanos
CG, Bell WJ, O’Rourke P,Kauper K, Sherman S, Stabila P and
Tao W. Sustained
secretion of ciliary neurotrophic factor to the vitreous, using
the encapsulated cell therapy-based NT-501 intraocular device.
Tissue Engineering, Vol. 10 (11/12):1617-1622. 2004.
Bush
RA, Lei B, Tao W, Raz D, Chan CC, Cox TA, Santos-Muffley M, and
Sieving PA. Encapsulated
cell-based intraocular delivery of ciliary neurotrophic factor
in normal rabbit: Dose-dependent effect on ERG and retinal histology.IOVS,
Vol. 45 (7) 2420-2430. 2004.
Song
Y, Zhao L,Tao W,Laties AM, Luo
Z, and Wen R. Photoreceptor
protection by cardiotrophin-1 in transgenic rats with the rhodopsin
mutation s334ter.
IOVS, 44(9):4069-75.
2003.
Tao
W, Wen R, Goddard MB, Sherman S, O’Rourke PJ, Stabila PF,
Bell WJ, Dean BJ, Kauper KA, Budz VA, Tsiaras WG, Acland GM, Pearce-Kelling
S, Laties AM, and Aguirre GD Encapsulated
Cell-Based Delivery of CNTF Reduces Photoreceptor Degeneration
in Animal Models of Retinitis Pigmentosa. IOVS, Vol. 43 (10)
3292-3298. 2002.
Hoane
MR, Puri KD, Xu L, Stabila PF, Zhao H, Gulwadi AG, Phillips HS,
Devaux B, Lindner MD, Tao W Mammalian-cell-produced
neurturin (NTN) is more potent than purified Escherichia coli-produced
NTN. Exp Neurol 162(1):189-93. 2000.
Hoane
MR, Gulwadi AG, Morrison S, Hovanesian G, Lindner MD, Tao W Differential
in vivo effects of neurturin and glial cell-line-derived neurotrophic
factor.Exp Neurol 160(1):235-43. 1999.
Lysaght,
M., and P. Aebischer. Encapsulated
cells as therapy. Scientific American 280:76. 1999.
Stabila
PF, Wong SC, Kaplan FA, Tao W Cell
surface expression of a human IgG Fc chimera activates macrophages
through Fc receptors. Nat Biotechnol 16(13):1357-60. 1998.
Tseng,
J. L., S. L. Bruhn, A. D. Zurn, and P. Aebischer. Neurturin
protects dopaminergic neurons following medial forebrain bundle
axotomy. Neuroreport 9:1817. 1998.
Sautter,
J., J. L. Tseng, D. Braguglia, P. Aebischer, C. Spenger, R. W.
Seiler, H. R. Widmer, and A. D. Zurn. Implants
of polymer-encapsulated genetically modified cells releasing glial
cell line-derived neurotrophic factor improve survival, growth,
and function of fetal dopaminergic graft. Exp Neurol 149:230.
1998.
Emerich,
D. F., C. K. Cain, C. Greco, J. A. Saydoff, Z. Y. Hu, H. Liu,
and M. D. Lindner. Cellular
delivery of human CNTF prevents motor and cognitive dysfunction
in a rodent model of Huntington's disease. Cell Transplant
6:249. 1997.
Emerich, D.
F., S. R. Winn, P. M. Hantraye, M. Peschanski, E. Y. Chen, Y.
Chu, P. McDermott, E. E. Baetge, and J. H. Kordower. Protective
effect of encapsulated cells producing neurotrophic factor CNTF
in a monkey model of Huntington's disease. Nature 386:395.
1997.
Tseng,
J. L., E. E. Baetge, A. D. Zurn, and P. Aebischer. GDNF
reduces drug-induced rotational behavior after medial forebrain
bundle transection by a mechanism not involving striatal dopamine.
J Neurosci 17:325. 1997.
Aebischer
P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard M,
Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE Intrathecal
delivery of CNTF using encapsulated genetically modified xenogeneic
cells in amyotrophic lateral sclerosis patients. Nat Med 2(6):696-9.
1996.
Aebischer
P, Pochon NA, Heyd B, Deglon N, Joseph JM, Zurn AD, Baetge EE,
Hammang JP, Goddard M, Lysaght M, Kaplan F, Kato AC, Schluep M,
Hirt L, Regli F, Porchet F, De Tribolet N Gene
therapy for amyotrophic lateral sclerosis (ALS) using a polymer
encapsulated xenogenic cell line engineered to secrete hCNTF.
Hum Gene Ther 1;7(7):851-60. 1996.
Emerich,
D. F., M. D. Lindner, S. R. Winn, E. Y. Chen, B. R. Frydel, and
J. H. Kordower. Implants
of encapsulated human CNTF-producing fibroblasts prevent behavioral
deficits and striatal degeneration in a rodent model of Huntington's
disease. J Neurosci 16:5168. 1996.
Emerich,
D. F., M. Plone, J. Francis, B. R. Frydel, S. R. Winn, and M.
D. Lindner. Alleviation
of behavioral deficits in aged rodents following implantation
of encapsulated GDNF-producing fibroblasts. Brain Res 736:99.
1996.
Kordower,
J. H., E. Y. Chen, E. J. Mufson, S. R. Winn, and D. F. Emerich.
Intrastriatal
implants of polymer encapsulated cells genetically modified to
secrete human nerve growth factor: trophic effects upon cholinergic
and noncholinergic striatal neurons. Neuroscience 72:63. 1996.
Lindner,
M. D., S. R. Winn, E. E. Baetge, J. P. Hammang, F. T. Gentile,
E. Doherty, P. E. McDermott, B. Frydel, M. D. Ullman, T. Schallert,
and et al. Implantation
of encapsulated catecholamine and GDNF-producing cells in rats
with unilateral dopamine depletions and parkinsonian symptoms.
Exp Neurol 132:62. 1995.
Sagot,
Y., S. A. Tan, E. Baetge, H. Schmalbruch, A. C. Kato, and P. Aebischer.
Polymer
encapsulated cell lines genetically engineered to release ciliary
neurotrophic factor can slow down progressive motor neuronopathy
in the mouse. Eur J Neurosci 7:1313. 1995.
Winn,
S. R., J. P. Hammang, D. F. Emerich, A. Lee, R. D. Palmiter, and
E. E. Baetge. Polymer-encapsulated
cells genetically modified to secrete human nerve growth factor
promote the survival of axotomized septal cholinergic neurons.
Proc Natl Acad Sci U S A 91:2324. 1994.
Aebischer
P, Buchser E, Joseph JM, Favre J, de Tribolet N, Lysaght M, Rudnick
S, Goddard M Transplantation
in humans of encapsulated xenogeneic cells without immunosuppression.
A preliminary report. Transplantation 15;58(11):1275-7. 1994.
Emerich,
D. F., J. P. Hammang, E. E. Baetge, and S. R. Winn. Implantation
of polymer-encapsulated human nerve growth factor- secreting fibroblasts
attenuates the behavioral and neuropathological consequences of
quinolinic acid injections into rodent striatum. Exp Neurol
130:141. 1994.
Emerich,
D. F., S. R. Winn, J. Harper, J. P. Hammang, E. E. Baetge, and
J. H. Kordower. Implants
of polymer-encapsulated human NGF-secreting cells in the nonhuman
primate: rescue and sprouting of degenerating cholinergic basal
forebrain neurons. J Comp Neurol 349:148. 1994.
Kordower, J. H., S. R. Winn, Y. T. Liu, E. J. Mufson, J. R. Sladek, Jr., J. P. Hammang, E. E. Baetge, and D. F. Emerich. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci U S A 91:10898. 1994.
